Bingnan Ren

Bingnan Ren

Auto-generated profile, based on publicly available information

Bingnan Ren

The Reproductive Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2021 in Frontiers in Endocrinology
Verified
Journal Article
Open access
JZJunwei Zhang
Junwei Zhang
MDMingze Du
Mingze Du
ZLZhen Li
Zhen Li
WLWenxia Liu
Wenxia Liu
BRBingnan Ren
Bingnan Ren
GYGuan Yichun
Guan Yichun
Objective: To compare the clinical outcomes of dydrogesterone (DYG) and medroxyprogesterone (MPA) in the progestin-primed ovarian stimulation (PPOS) protocol for patients with poor ovarian response (POR).Patients and Methods: This was a retrospective cohort study. Women with POR who underwent IVF/ICSI at the Reproductive Center of Third Affiliated Hospital of Zhengzhou University between January 2020 and January 2021 were included. The primary outcome measure of our study was the number of oocytes retrieved. The secondary outcome measures in the present study were the number of 2PN, number of available embryos, oocyte retrieval rate, fertilization rate, viable embryo rate per oocyte retrieved, cancellation rate and pregnancy outcomes of the first embryo transfer cycle, including the biochemical pregnancy, clinical pregnancy and miscarriage rates.Results: In total, 118 women underwent hMG +DYG protocols, and 692 women who underwent hMG +MPA met the Bologna criteria for POR. After baseline characteristics were balanced using the PSM model, 118 hMG +DYG protocols were matched to 118 hMG +MPA protocols, and the baseline characteristics were comparable between the two groups. The numbers of oocytes retrieved, 2PN, and available embryos and the oocyte retrieval rate, fertilization rate, viable embryo rate per oocyte retrieved and cancellation rate of the hMG+DYG and hMG+MPA protocols were comparable. Altogether, 66 women in the hMG+DYG group and 87 women in the hMG+MPA group underwent first embryo transfers. In the hMG+DYG group, 81.8% (54/66) of the patients underwent cleavage embryo transfers; similarly, 79.3% (69/87) of patients in the hMG+MPA group had cleavage embryo transfers (P=0.70).The biochemical pregnancy rate of the hMG+DYG group was 42.4%, and this was comparable to the rate in the hMG+DYG group, at 34.5% (P=0.32). The clinical pregnancy rates were similar between the two groups (36.4% vs. 31.0%, P=0.49), and there was no significant difference in the rate of miscarriage between the two groups (12.5% vs. 29.6%, P=0.14).Conclusion: For women with POR, the clinical outcome of the hMG + DYG group was similar to that of the hMG + MPA group, indicating that both combinations can be useful options for PPOS protocols.

20 May 2019 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
BRBingnan Ren
Bingnan Ren
DTDandan Tian
Dandan Tian
LWLianke Wang
Lianke Wang
HHHan Han
Han Han
WWWenhua Wang
Wenhua Wang
WZWei Dong Zhang
Wei Dong Zhang

11 January 2009 in Chromatographia
Verified
Journal Article
Closed access
PDF file
XFXiaojuan Feng
Xiaojuan Feng
HLHaiyan Liu
Haiyan Liu
GYGengliang Yang
Gengliang Yang
BRBingnan Ren
Bingnan Ren
XYXinru Yang
Xinru Yang
GYGuanqun Yang
Guanqun Yang